Neuroendocrine Tumors Market

1
Neuroendocrine Tumors (NET)
Market Insights, Epidemiology, and Market
Forecast- 2028
2
NEUROENDOCRINE TUMORS (NET)

• DelveInsight 2019 All rights reserved

3
NEUROENDOCRINE TUMORS EPIDEMIOLOGY
7MM includes - USA, EU-5 (Germany, Spain,
Italy, France and UK), Japan

• DelveInsight 2019 All rights reserved

4
NEUROENDOCRINE TUMORS MARKET
Neuroendocrine tumors therapeutic market in seven
major markets was USD 3,570.0 million in 2017.
The United States accounts for the largest
Neuroendocrine tumors market size, in comparison
to EU5 (the United Kingdom, Germany, Italy,
France, and Spain) and Japan.
Among the EU5 countries, Germany had the highest
Neuroendocrine tumors market size with
approximately USD 330.0 million in 2017.
Spain had the lowest Neuroendocrine tumors market
size with approximately USD 180.0 million in 2017.

• DelveInsight 2019 All rights reserved

5
NETs MARKET () DISTRIBUTION IN 2017
United States
Japan
United Kingdom
Germany
France
Italy
Spain
5.1
51.7
12.7
9.3
7.6
6.9
6.7

• DelveInsight 2019 All rights reserved

6
NETs MARKET SIZE BY THERAPIES
Drug- CRN01941 by Crinetics Pharmaceuticals
Drug- RRx-001 By EpicentRx
Drug- ATG-008 By Antengene
Neuroendocrine Tumors market dynamics is
anticipated to change in the coming years owing
to the expected launch of emerging therapies
during the forecasted period of 2019-2028. The
emerging therapies and companies involved in
Neuroendocrine Tumors treatment are-
Drug- Sulfatinib By Hutchison MediPharma
Drug- Entrectinib By Ignyta

• DelveInsight 2019 All rights reserved

7
COMPLETE INFORMATION
For complete information on Neuroendocrine
Tumors Market Insights, Epidemiology Market
Forecast-2028 please click the link below
CLICK HERE
OR
Write Us At 
info_at_delveinsight.com

• DelveInsight 2019 All rights reserved

8
ABOUT DELVEINSIGHT
ABOUT
VISION
MISSION
DelveInsight is a premier Business Consulting and
Market Research firm focused exclusively on the
life science segment. With a wide array of smart
end-to-end solutions, the firm helps the global
Pharmaceutical and Bio-Tech companies formulate
prudent business decisions for improving their
performances to stay ahead of the competitors.
To be the most trusted market research business
consulting firm in the world and to continue
enable the Pharma Bio-Tech companies to achieve
their goals with the best strategic insight and
competitive solution. The vision also is
inclusive of becoming a one-stop solution
provider for the entire gamut of drug development
process.
To provide insights across the value chain and
helping the organization to take a prudent
business decision through the use and analysis of
actionable market intelligence. The mission also
is to provide the most effective result and
efficient service with utmost client care for
maintaining a long-term relationship with them.

• DelveInsight 2019 All rights reserved

9
SERVICE OFFERINGS BY DELVEINSIGHT
OPPORTUNITY ASSESSMENT
1
5
FORECASTING
2
6
PIPELINE
REPORT STORE
COMPETITIVE ANALYSIS
3
7
CONSULTING
MARKET INTELLIGENCE
4
8
PHARMDELVE

• DelveInsight 2019 All rights reserved

10
CONTACT US
blog/delveInsight/
info_at_delveinsight.com
91-11-4568 9769
twitter/delveInsight
LinkedIn/delveInsight
www.delveinsight.com

• DelveInsight 2019 All rights reserved

11
THANK YOU